Someno T, Saino T, Katoh K, Miyazaki H, Ishii S
J Biochem. 1985 May;97(5):1493-500. doi: 10.1093/oxfordjournals.jbchem.a135204.
Pyroglutamyl-lysyl-leucyl-argininal (Pyr-Lys-Leu-Argal) immobilized on gel matrix through the epsilon-amino group of its lysine residue was shown to be an efficient biospecific affinity adsorbent for purification of urokinase. Pyr-Lys-Leu-Argal dibutylacetal, a precursor of this immobilized ligand, was synthesized by a fragment condensation procedure, in which one of the thermolysin-digestion products of leupeptin dibutylacetal, H-Leu-Argal dibutylacetal, was used as a key intermediate. The precursor was coupled to CH-Sepharose 4B with the aid of a water-soluble carbodiimide, and its acetal protecting group was then removed by mild acid treatment to free the essential aldehyde function. The Sepharose derivative thus prepared was shown to adsorb urokinase selectively and effectively from a crude human urine preparation at neutral pH and to release the bound enzyme under mild acidic conditions. The present technique afforded a highly purified urokinase preparation abundant in the high-molecular form with 90% recovery. The complex formed between urokinase and the immobilized ligand was found to have a dissociation constant of about 2 X 10(-4)M.
通过其赖氨酸残基的ε-氨基固定在凝胶基质上的焦谷氨酰-赖氨酰-亮氨酰-精氨醛(Pyr-Lys-Leu-Argal)被证明是一种用于纯化尿激酶的高效生物特异性亲和吸附剂。这种固定化配体的前体Pyr-Lys-Leu-Argal二丁基缩醛是通过片段缩合程序合成的,其中亮抑酶肽二丁基缩醛的嗜热菌蛋白酶消化产物之一H-Leu-Argal二丁基缩醛用作关键中间体。前体借助水溶性碳二亚胺与CH-Sepharose 4B偶联,然后通过温和的酸处理去除其缩醛保护基团以释放必需的醛官能团。如此制备的琼脂糖衍生物在中性pH下能从粗制人尿制剂中选择性且有效地吸附尿激酶,并在温和酸性条件下释放结合的酶。本技术得到了高分子形式丰富的高度纯化尿激酶制剂,回收率达90%。发现尿激酶与固定化配体形成的复合物的解离常数约为2×10^(-4)M。